Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-10-011225
Filing Date
2010-07-01
Accepted
2010-07-01 19:42:40
Documents
1
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 6716
  Complete submission text file 0001179110-10-011225.txt   8638
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

EIN.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2483 EAST BAYSHORE ROAD SUITE 100 PALO ALTO CA 94303
Business Address
Ketchum Steven B (Reporting) CIK: 0001289884 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 10932240